Wafik S. El-Deiry, M.D.,Ph.D.

Wafik S. El-Deiry, M.D.,Ph.D.
Penn State Cancer Institute
500 University Drive
Hershey, PA 17033

Fellowship, Medical Oncology
Johns Hopkins Hospital (Maryland) - 1994

Internship, Internal Medicine
Johns Hopkins Hospital (Maryland) - 1990

University of Miami School of Medicine (Florida) - 1987

  • Clinical Trials
  • Colorectal Cancer
  • Palliative Care
  • Solid Malignancies
  • Professor of Medicine, Chief, Hematology/Oncology
  • Rose Dunlap Division Chair in Hematology/Oncology
  • Associate Director for Translational Research, Cancer Institute
  • 2009: American Cancer Society Research Professorship
  • 2008, 2009: Citation in "America's Top Oncologists" by the Consumers' Research Council of America
  • 2006: American Association for Cancer Research Littlefield Award for research on metastatic colon cancer
  • 2005: ISI Highly Cited Researcher in Molecular Biology and Genetics
Dr. El-Deiry is committed to translational cancer research focused on bringing new biomarkers and novel therapies into the clinic. He enjoys teaching, clinical work, serving on review panels, editorial boards (including as Founding Editor-in-Chief of Cancer Biology and Therapy since 2001 http://www.landesbioscience.com/journals/cbt) and training future scientists and clinicians. Dr. El-Deiry is a member of the American Society for Clinical Investigation, the American Association for Cancer Research, the American Society for Clinical Oncology, the Interurban Clinical Club, and the Association of American Physicians.
  • 2008: Elected Secretary/Treasurer, Interurban Clinical Club, an honor society for physicians started by Sir William Osler in 1905, http://interurbanclinicalclub.org/
  • 2008: Elected Member, Association of American Physicians
  • 2007-2010: Associate Editor, Journal of Clinical Investigation
  • BRCA1
  • Cancer cell death
  • Cancer drug discovery and development
  • Cancer stem cells
  • Circulating tumor cells
  • Hypoxia and tumor microenvironment
  • In vivo molecular imaging
  • Mouse models of human cancer
  • P53 and TRAIL signaling
  • Resistance to anti-cancer drugs

My Practice Locations

My Practice Locations